Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Shijiazhuang Yiling Pharmaceutical (002603)
- 16.67
- +0.02+0.12%
Not Open Apr 24 15:00 CST
27.85BMarket Cap-99.82P/E (TTM)
16.73High16.34Low126.02KlotVolume16.57Open16.65Prev Close209.54MTurnover0.92%Turnover RatioLossP/E (Static)1.67BShares21.5852wk High2.60P/B22.95BFloat Cap13.3552wk Low18.32Limit Up1.38BShs Float52.86Historical High14.99Limit Down2.34%Range %4.49Historical Low0.30Dividend TTM16.63Avg Price66.00KlotAsk1.80%Div Yield TTM100Lot Size54.46KlotBid
Shijiazhuang Yiling Pharmaceutical (002603) Balance Sheet
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 14.01%1.03B | -15.00%1.04B | -15.68%1B | -9.30%853.03M | -15.41%907.31M | -30.28%1.22B | 14.88%1.19B | -50.61%940.51M | -39.08%1.07B | 1.93%1.76B |
| Transactional financial assets | 10,016.67%910.5M | --560.5M | 43.73%163M | ---- | -96.19%9M | ---- | -91.87%113.4M | -60.27%205.97M | -7.32%236.01M | 287.81%404.67M |
| Notes receivable and accounts receivable | -50.32%1.38B | -49.09%1.4B | -37.29%1.61B | -49.05%1.23B | 11.67%2.78B | 22.17%2.75B | 32.22%2.56B | 39.29%2.41B | 24.53%2.49B | 11.34%2.25B |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4M | ---- | ---- |
| -Accounts receivable | -50.32%1.38B | -49.09%1.4B | -37.29%1.61B | -48.97%1.23B | 11.67%2.78B | 22.17%2.75B | 32.22%2.56B | 39.05%2.4B | 24.53%2.49B | 11.34%2.25B |
| Other receivables (including interest and dividends) | -27.44%18.97M | 71.56%17.75M | 213.39%18.55M | 2,325.55%129.85M | 299.75%26.15M | 63.31%10.35M | -5.78%5.92M | -3.88%5.35M | -21.93%6.54M | -10.08%6.34M |
| -Other receivable | ---- | 71.56%17.75M | ---- | ---- | ---- | 63.31%10.35M | ---- | -3.88%5.35M | ---- | -10.08%6.34M |
| Advance payment | -47.62%77.71M | -50.63%69.04M | -14.82%95.63M | -51.90%52.77M | -36.56%148.35M | -34.24%139.82M | -61.76%112.27M | -78.75%109.71M | -42.77%233.85M | 13.25%212.62M |
| Inventories | -13.18%1.69B | -23.45%1.47B | -30.75%1.39B | -28.97%1.75B | -20.02%1.94B | -23.68%1.92B | -29.10%2B | 21.61%2.46B | 44.26%2.43B | 28.38%2.51B |
| Receivable financing | 21.04%374.36M | 54.74%556.23M | -15.11%463.37M | -13.89%164.68M | 87.34%309.28M | 91.14%359.46M | -29.08%545.87M | -57.58%191.24M | -81.99%165.09M | -64.53%188.07M |
| Other current assets | -9.19%58.34M | -58.65%56.51M | -53.86%57.71M | -28.31%162.81M | -67.24%64.25M | 7.70%136.65M | -36.94%125.07M | 106.18%227.08M | 136.67%196.11M | 101.29%126.88M |
| Total current assets | -10.41%5.54B | -20.95%5.17B | -27.97%4.79B | -33.75%4.33B | -9.40%6.18B | -12.33%6.54B | -21.32%6.66B | -9.79%6.54B | -4.03%6.82B | 13.11%7.46B |
| Non Current assets | ||||||||||
| Other non-current financial assets | ---- | ---- | ---- | -99.94%1M | -15.74%1.65B | -19.91%1.64B | -11.82%1.62B | 22.42%1.65B | 196,214.53%1.96B | 204,762.78%2.05B |
| Investment real estate | 137.01%55.37M | 136.33%56.36M | 214.51%60.68M | 152.02%62.56M | -12.89%23.36M | 5.81%23.85M | -16.99%19.29M | 6.32%24.82M | 9.89%26.82M | -4.67%22.54M |
| Long-term equity investment | -0.46%2.46M | -0.42%2.47M | -0.46%2.47M | -0.46%2.47M | -0.54%2.47M | -0.46%2.48M | -0.72%2.48M | -0.60%2.48M | -0.52%2.49M | -0.51%2.49M |
| Fixed assets | ---- | -3.03%5.76B | ---- | ---- | ---- | 9.60%5.94B | ---- | 25.72%5.81B | ---- | 41.05%5.42B |
| Constru in process | ---- | -4.59%1.28B | ---- | ---- | ---- | -14.42%1.34B | ---- | -6.59%1.47B | ---- | -24.74%1.57B |
| Productive biological assets | 388.92%22.87M | 219.50%19.22M | 217.36%17.28M | 190.36%16.13M | -44.61%4.68M | -18.29%6.01M | -29.22%5.44M | -26.17%5.55M | -41.97%8.45M | -35.05%7.36M |
| Intangible assets | 8.89%785.32M | 8.75%792.47M | 8.03%795.47M | 7.94%802.57M | -4.02%721.23M | -3.93%728.74M | 2.60%736.34M | 2.69%743.52M | -3.87%751.42M | -2.14%758.54M |
| Development expenditure | 49.10%323.17M | 48.70%298.79M | 40.81%270.13M | 41.70%262.8M | 37.73%216.74M | 65.53%200.94M | 72.91%191.84M | 78.43%185.47M | -29.80%157.37M | -45.46%121.4M |
| Goodwill | -5.62%104.83M | -5.54%106.39M | -5.46%107.95M | -5.39%109.51M | -2.77%111.07M | -1.41%112.63M | --114.19M | --115.75M | --114.24M | --114.24M |
| Long deferred expense | -30.70%3.26M | -3.73%3.03M | 31.06%4.47M | 4.62%4.08M | 80.65%4.71M | 11.99%3.15M | 12.99%3.41M | 21.07%3.9M | 9.41%2.61M | 74.32%2.81M |
| Deferred tax assets | 108.58%307.69M | 87.57%307.48M | 118.39%385.17M | 99.28%365.84M | 24.95%147.52M | -1.28%163.93M | -31.27%176.37M | -35.46%183.58M | -28.98%118.07M | -11.55%166.06M |
| Usufruct assets | 35.80%32.3M | 35.80%34.45M | 38.10%26.72M | 36.30%27.99M | 30.43%23.78M | 27.00%25.37M | -6.20%19.35M | -8.23%20.53M | -3.43%18.23M | -6.66%19.97M |
| Other non current assets | -61.95%82.28M | -68.76%69.89M | -54.10%128.48M | -44.20%120.84M | -54.44%216.27M | -49.64%223.69M | -40.40%279.92M | -41.36%216.57M | -12.33%474.71M | -28.08%444.22M |
| Total non current assets | -16.78%8.68B | -16.16%8.73B | -15.02%8.9B | -13.91%8.98B | -1.69%10.43B | -2.64%10.41B | 7.00%10.47B | 14.85%10.44B | 35.80%10.61B | 37.29%10.7B |
| Total assets | -14.41%14.22B | -18.01%13.9B | -20.05%13.69B | -21.56%13.32B | -4.71%16.61B | -6.62%16.95B | -6.13%17.13B | 3.91%16.98B | 16.82%17.44B | 26.21%18.15B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | ---- | ---- | -33.34%600.29M | -54.00%460.26M | -14.28%600.36M | 19.99%600.35M | 124.97%900.5M | 233.27%1B |
| Notes payable and accounts payable | -29.12%1.81B | -30.80%1.77B | -30.19%1.89B | -33.37%1.9B | 10.48%2.55B | -10.76%2.55B | -2.77%2.71B | 38.13%2.85B | -2.66%2.31B | 24.17%2.86B |
| -Notes payable | -98.79%7.19M | -86.78%83.26M | -83.34%126.07M | -93.08%50M | 40.74%592.56M | 11.65%629.84M | 20.12%756.69M | 24.42%722.79M | -26.66%421.03M | 89.62%564.12M |
| -Accounts payable | -8.01%1.8B | -12.46%1.68B | -9.62%1.77B | -13.05%1.85B | 3.72%1.96B | -16.27%1.92B | -9.45%1.95B | 43.51%2.12B | 5.02%1.89B | 14.46%2.3B |
| Contract liabilities | 97.15%342.08M | 49.97%409.21M | 6.86%360.26M | -5.28%272.34M | -18.42%173.51M | -35.19%272.85M | -71.78%337.12M | -74.00%287.52M | -63.41%212.69M | -13.82%421.03M |
| Salaries payable | -11.24%182.91M | -14.13%201.57M | -0.25%249.09M | 0.74%283.23M | -12.59%206.08M | -11.72%234.74M | -18.78%249.71M | -25.97%281.15M | 43.33%235.76M | 51.14%265.9M |
| Taxs payable | 21.25%109.28M | -14.39%89.25M | -37.29%86.94M | -55.04%76.38M | -49.94%90.13M | -31.99%104.25M | -52.40%138.65M | -64.16%169.89M | -47.01%180.03M | -36.67%153.29M |
| Other payable (including interest and dividends) | 77.36%543.31M | -92.34%41M | 40.39%44.78M | 12.21%48.48M | -42.65%306.33M | -41.83%535.54M | -63.62%31.9M | -64.09%43.2M | 1,798.32%534.12M | 74.86%920.6M |
| -Dividend payable | 82.87%501.21M | ---- | ---- | ---- | -39.34%274.08M | -39.64%501.21M | ---- | ---- | --451.8M | 65.67%830.35M |
| -Other payable | ---- | 19.45%41M | ---- | ---- | ---- | -61.96%34.32M | ---- | -64.09%43.2M | ---- | 257.02%90.24M |
| Non current liabilities due within one year | 226.68%9.85M | -95.21%9.75M | -96.18%7.76M | -96.01%8.24M | -31.57%3.02M | 3,741.99%203.69M | 30.94%203.05M | 32.46%206.62M | -65.91%4.41M | -97.52%5.3M |
| Other current liabilities | -31.17%7.12M | -12.67%9.23M | 45.55%19.7M | 87.69%21.45M | -42.70%10.34M | -14.92%10.57M | -64.06%13.54M | -78.53%11.43M | -94.60%18.05M | 36.70%12.42M |
| Total current liabilities | -23.80%3B | -42.25%2.53B | -37.90%2.66B | -41.38%2.61B | -10.34%3.94B | -22.43%4.37B | -22.96%4.29B | -8.32%4.45B | 3.82%4.39B | 32.40%5.64B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | -4.75%667.1M | 99.36%598.4M | 199.16%598.73M | 199.33%599.1M | 99.97%700.4M | 99.96%300.16M |
| Deferred tax liabilities | -13.05%110.68M | -12.80%112.39M | -13.66%112.69M | -12.21%114.25M | 1.26%127.3M | 3.33%128.89M | 1,718.48%130.53M | 1,171.38%130.14M | 10,231.62%125.72M | 10,286.46%124.74M |
| Long term deferred income | 4.08%390.92M | 1.86%371.48M | 4.47%374.96M | 7.25%377.92M | 5.44%375.59M | -3.72%364.69M | 8.49%358.93M | 5.18%352.37M | 0.30%356.22M | 7.79%378.78M |
| Lease liabilities | -1.05%20.48M | 0.22%21.8M | 28.74%19.09M | 39.94%18.21M | 63.43%20.69M | 63.85%21.75M | 5.62%14.83M | -13.08%13.01M | 434.32%12.66M | 422.92%13.27M |
| Total non current liabilities | -56.15%522.08M | -54.60%505.67M | -54.06%506.74M | -53.37%510.39M | -0.36%1.19B | 36.33%1.11B | 99.75%1.1B | 95.34%1.09B | 68.55%1.19B | 61.69%816.96M |
| Total liabilities | -31.31%3.52B | -44.75%3.03B | -41.21%3.17B | -43.75%3.12B | -8.21%5.13B | -15.00%5.49B | -11.87%5.39B | 2.42%5.54B | 13.11%5.59B | 35.50%6.46B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B |
| Capital reserve funds | -0.81%2.32B | -0.81%2.32B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B |
| Surplus reserve funds | 0.00%936.76M | 0.00%936.76M | 0.00%936.76M | 0.00%936.76M | -0.00%936.76M | -0.00%936.76M | -0.00%936.76M | 0.00%936.76M | 23.40%936.77M | 23.40%936.77M |
| Retained profit | -11.89%5.78B | -8.97%5.95B | -17.68%5.61B | -18.84%5.28B | -5.10%6.56B | -3.32%6.54B | -5.31%6.81B | 8.63%6.51B | 32.44%6.91B | 39.27%6.76B |
| Other composite income | -15.89%-7.02M | -9.77%-7.24M | -7.96%-7.18M | -7.67%-7.12M | 4.15%-6.06M | -5.92%-6.59M | 3.31%-6.65M | 8.38%-6.61M | 15.30%-6.32M | 27.91%-6.22M |
| Shareholders equity without minority interests | -6.95%10.7B | -5.28%10.87B | -10.25%10.55B | -10.71%10.22B | -2.97%11.5B | -1.92%11.48B | -3.14%11.75B | 4.73%11.45B | 18.75%11.86B | 21.69%11.7B |
| Minority interests | 66.00%-6.19M | 63.40%-5.69M | -68.85%-23.19M | -82.44%-21.4M | -116.68%-18.2M | -134.97%-15.56M | -354.34%-13.74M | -502.77%-11.73M | -1,009.75%-8.4M | -482.94%-6.62M |
| Total shareholder equity | -6.86%10.7B | -5.20%10.87B | -10.34%10.53B | -10.81%10.2B | -3.06%11.49B | -2.00%11.46B | -3.23%11.74B | 4.65%11.44B | 18.65%11.85B | 21.60%11.7B |
| Total liabilityies and equity | -14.41%14.22B | -18.01%13.9B | -20.05%13.69B | -21.56%13.32B | -4.71%16.61B | -6.62%16.95B | -6.13%17.13B | 3.91%16.98B | 16.82%17.44B | 26.21%18.15B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm